CNR Institutional Research Information System

BISOGNO, TIZIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.810
NA - Nord America 1.862
SA - Sud America 761
EU - Europa 705
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 45
OC - Oceania 6
Totale 7.254
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.735
SG - Singapore 1.568
CN - Cina 826
BR - Brasile 584
HK - Hong Kong 458
VN - Vietnam 356
IT - Italia 231
FR - Francia 225
KR - Corea 159
BD - Bangladesh 93
JP - Giappone 90
IN - India 57
CA - Canada 48
DE - Germania 46
CO - Colombia 45
AR - Argentina 42
GB - Regno Unito 41
EC - Ecuador 39
ID - Indonesia 37
NL - Olanda 32
IL - Israele 25
FI - Finlandia 23
MX - Messico 20
SA - Arabia Saudita 19
PK - Pakistan 18
VE - Venezuela 18
JM - Giamaica 16
ZA - Sudafrica 16
ES - Italia 15
RU - Federazione Russa 15
IQ - Iraq 14
PH - Filippine 13
AT - Austria 12
CR - Costa Rica 11
MY - Malesia 11
UA - Ucraina 11
PY - Paraguay 10
TR - Turchia 10
CL - Cile 9
MA - Marocco 9
PL - Polonia 9
TT - Trinidad e Tobago 8
UZ - Uzbekistan 8
KE - Kenya 7
NP - Nepal 7
PE - Perù 7
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
EG - Egitto 6
TN - Tunisia 6
AL - Albania 5
AU - Australia 5
NI - Nicaragua 5
TW - Taiwan 5
BG - Bulgaria 4
ET - Etiopia 4
IE - Irlanda 4
JO - Giordania 4
KZ - Kazakistan 4
LT - Lituania 4
TH - Thailandia 4
BB - Barbados 3
BO - Bolivia 3
DZ - Algeria 3
EE - Estonia 3
GR - Grecia 3
HN - Honduras 3
PR - Porto Rico 3
PT - Portogallo 3
UY - Uruguay 3
BE - Belgio 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
NG - Nigeria 2
OM - Oman 2
QA - Qatar 2
SC - Seychelles 2
SE - Svezia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
CH - Svizzera 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GF - Guiana Francese 1
GM - Gambi 1
GP - Guadalupe 1
HR - Croazia 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
Totale 7.194
Salva come PNG Salva come JPEG
Città #
Singapore 943
Hong Kong 449
Hefei 382
Santa Clara 331
San Jose 195
Ashburn 182
Lauterbourg 176
Beijing 163
Seoul 156
Ho Chi Minh City 124
Hanoi 82
Rome 82
Los Angeles 66
Tokyo 63
São Paulo 43
Dallas 33
New York 28
Council Bluffs 25
Da Nang 24
Rio de Janeiro 24
Minamishinagawa 22
Frankfurt am Main 21
Chicago 20
Helsinki 18
Phoenix 18
Buffalo 17
Milan 15
Philadelphia 15
Bengaluru 13
Dhaka 13
Naples 13
Brooklyn 12
Kingston 12
Atlanta 10
Brasília 10
Guarulhos 10
Guayaquil 10
Haiphong 10
Belo Horizonte 9
Bogotá 9
Curitiba 9
Houston 9
Porto Alegre 9
Quito 9
San José 9
Hải Dương 8
Medellín 8
Newark 8
Salvador 8
Tashkent 8
Biên Hòa 7
Boardman 7
Campinas 7
Cleveland 7
Duque de Caxias 7
Düsseldorf 7
Elk Grove Village 7
Nanjing 7
Vienna 7
Warsaw 7
Buenos Aires 6
Cape Town 6
Dammam 6
Karachi 6
Lancaster 6
London 6
Montreal 6
Nairobi 6
Phủ Lý 6
Queens 6
Baku 5
Cairo 5
Casablanca 5
Dublin 5
Florence 5
Greenville 5
Jeddah 5
Johannesburg 5
Lexington 5
Ludhiana 5
Lấp Vò 5
Managua 5
Nuremberg 5
Orem 5
Orlando 5
Pune 5
Sydney 5
Thái Bình 5
Toronto 5
Virginia Beach 5
Wuhan 5
Addis Ababa 4
Amman 4
Baghdad 4
Bandung 4
Bari 4
Cagliari 4
Caldas Novas 4
Detroit 4
Franca 4
Totale 4.204
Salva come PNG Salva come JPEG
Nome #
Bioactive Lipids in Health and Disease 98
Pharmacological inhibition of the CB1 cannabinoid receptor restores abnormal brain mitochondrial CB1 receptor expression and rescues bioenergetic and cognitive defects in a female mouse model of Rett syndrome 95
Cannabinoids and the expanded endocannabinoid system in neurological disorders 85
Fatty acid amide hydrolase (FAAH) inhibition modulates amyloid-beta-induced microglia polarization 81
Circulating Endocannabinoids in Canine Cutaneous Mast Cell Tumor 81
Interactions of non-THC phytocannabinoids and Cannabis extracts with TRP channels and endocannabinoid metabolic enzymes 79
Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington?s disease 77
N-Acyl Amino Acids: Metabolism, Molecular Targets, and Role in Biological Processes 74
Anandamide: Endocannabinoid, endovanilloid, or both? 73
The cannabimimetic eicosanoid, anandamide, regulated rat brain protein kinase C and mouse macrophage arachidonate release 68
Targeted Lipidomics Investigation of N-acylethanolamines in a Transgenic Mouse Model of AD: A Longitudinal Study 65
The Endocannabinoid System: A Bridge between Alzheimer’s Disease and Gut Microbiota 64
Different Routes to Inhibit Fatty Acid Amide Hydrolase: Do All Roads Lead to the Same Place? 64
Anandamide receptors 61
Endocannabinoids Part I: Molecular basis of endocannabinoid formation, action and inactivation and development of selective inhibitors 61
The sleep inducing factor oleamide is produced by mouse neuroblastoma cells 61
Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats 59
A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects 59
Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa 59
'Endocannabinoids', endogenous phospholipid-derived metabolites with cannabimimetic properties: biosynthesis and catabolism 58
Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase. 58
Synthesis and pharmacological activity of a potent inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol. 57
Cannabinoid CB1 receptor activation inhibits MPTP-induced expression of S100B in glial cells thereby leading to survival of co-cultured neurons. Mechanism of action and involvement of endocannabinoids 57
Tetrahydrolipstatin analogues: new selective pharmacological tools to investigate 2-AG metabolism 56
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation 56
BIONOTE as an innovative biosensor for measuring endocannabinoid levels 56
In vitro and in vivo pharmacology of synthetic olivetol-derived cannabinoid receptor ligands. 55
2-arachidonoylglycerol levels are increased in leukocytospermia and correlate with seminal macrophages 54
Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100 ² up-regulation in vitro 52
Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo. 52
Effects of glycated insulin on adipogenic differentiation 52
Circulating Endocannabinoids as Diagnostic Markers of Canine Chronic Enteropathies: A Pilot Study 51
Endocannabinoid signaling and its regulation by nutrients 50
Enzymes for 2-AG biosynthesis and metabolism in cell lines, and their pharmacological inhibition 50
Role of the Specialized Proresolving Mediator Resolvin D1 in Systemic Lupus Erythematosus: Preliminary Results 50
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors. 48
Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism 47
Limited Access to a High Fat Diet Alters Endocannabinoid Tone in Female Rats 47
Sclerostin Regulation, Microarchitecture, and Advanced Glycation End-Products in the Bone of Elderly Women With Type 2 Diabetes 45
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system. 45
N-acylvanillinamide derivatives capable of activating peripheral cannabinoid receptors 44
Biology of endocannabinoids 44
The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide 44
Endocannabinoids generated by Ca2+ or by metabotropic glutamate receptors appear to arise from different pools of diacylglycerol lipase. 43
Cannabimimetic fatty acid derivatives: Biosynthesis and catabolism 43
Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells 43
Cannabimimetic fatty acid derivatives: The anandamide family and other 'endocannabinoids' 43
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 42
Protective role of palmitoylethanolamide in contact allergic dermatitis 41
Endocannabinoidomics: targeted lipidomics methods for the study of endocannabinoid-related molecules in the CNS 40
The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG. 40
An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice. 40
Endocannabinoids 40
Potentation of cannabimimetic actions of 2-arachidonoyl-glycerol in vivo by non-cannabimimetic acyl-glycerols. Enhancement of receptor binding and inhibition of enzymatic hydrolysis 39
Exogenous anandamide protects rat brain against acute neuronal injury in vivo 39
Depolarization-induced retrograde synaptic inhibition in the cerebellar cortex is mediated by 2-arachidonoylglycerol 39
Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes 39
ESSENTIAL DIETARY BIOACTIVE LIPIDS IN NEUROINFLAMMATORY DISEASES. 39
Assay of DAGLalpha/beta Activity 39
Interactions between synthetic vanilloids and the endogenous cannabinoid system 39
Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. 38
Chemical synthesis, pharmacological characterization, and possible formation in unicellular fungi of 3-hydroxy-anandamide 38
Development of the first potent and specific inhibitors of endocannabinoid biosynthesis 38
FAAH inhibition elevates endocannabinoid levels in the periaqueductal grey of the rat: dual effect on nociception via CB1 and TRPV1 receptors 37
Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain 37
Metabolism of anandamide and 2-arachidonoylglycerol: An historical overview and some recent developments 36
The endogenous cannabinoid system controls extinction of aversive memories 36
Possible endocannabinoid control of colorectal cancer growth. 36
Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase 36
Evidence for an endocannabinoid system in the central nervous system of the leech Hirudo medicinalis 36
Fatty Acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications 36
The endocannabinoid system is modulated in response to spinal cord injury in rats. 36
Tonic control of tumoral growth by endocannabinoids. 35
N-acyl-dopamines: novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo 35
Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells - Implications for cell proliferation and differentiation 35
Alterations in the Endocannabinoid System as a Link Between Unbalanced Energy Homeostasis, Neuroinflammation, and Neurological and Neuropsychiatric Disorders 35
Cannabimimetic eicosanoids in cancer and inflammation: An update 35
Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues 34
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors. 34
Novel selective inhibitors of anandamide re-uptake with anti-spastic activity in a mouse model of multiple sclerosis. 33
Protective role of palmitoylethanolamide in keratinocytes and its involvement in contact allergic dermatitis. 32
Arachidonoylethyleneglycol and its nitroester as new cannabimimetics: Oxidation by 15-lipoxygenase and hydrolysis by fatty acid amide hydrolase 32
Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis 32
Endocannabinoids potently inhibit prolactin- and nerve growth factor-induced human prostate and breast cancer cell proliferation by acting at CB1 receptors 32
Neonatal stress-induced neurodegeneration: a suitable animal model to evaluate neuroprotective and modulatory properties of cannabinoids. 32
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes 32
Impaired endocannabinoid levels in selected brain areas of transgenic R6/2 mice, and experimental model of Huntington s disease. 31
On the toxification of anandamide by pathogenic fungi: formation of 3-hydroxy-anandamide and its activity on cannabinoid and TRPV1 receptors. 31
Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism. 31
Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders 31
Exogenous and endogenous cannabimimetic metabolites 31
Type-2 cannabinoid receptors in neurodegeneration 31
Arachidonoylethyleneglycol and its nitroester as New cannabimimetics: Oxidation by 15-Lipoxygenase and hydrolysis by Fatty Acid Amide hydrolase 31
Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice. 31
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide 31
Palmitoylethanolamide enhances the cytostatic effect of anandamide 31
LIPID PROFILING OF HIGH-FAT-FED MICE AFTER DIETARY KRILL OIL SUPPLEMENTATION 31
Endogenous cannabimimetic acyl-ethanolamides in immuno cells: biosynthesis, action and inactivation 30
Use of n-acylvanillinamide derivatives as agonists of peripheral cannabinoid cb1 receptors 30
Methods for measuring endocannabinoid production and expression and activity of enzymes involved in the endocannabinoid system 30
Totale 4.619
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.453
article - articoli 18.611
book - libri 132
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 695
Totale 45.891
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202435 0 0 0 0 0 0 0 0 5 0 22 8
2024/20252.216 24 8 170 123 341 38 7 83 34 113 644 631
2025/20264.116 213 419 440 658 670 149 629 234 248 189 149 118
2026/2027887 211 229 447 0 0 0 0 0 0 0 0 0
Totale 7.254